Woodline Partners’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Buy
1,317,932
+291
+0% +$1.15K 0.01% 706
2025
Q4
$5.36M Sell
1,317,641
-60,595
-4% -$271K 0.02% 612
2025
Q3
$4.89M Buy
1,378,236
+597,014
+76% +$2.16M 0.02% 572
2025
Q2
$2.13M Buy
781,222
+566
+0.1% +$1.17K 0.01% 714
2025
Q1
$1.31M Buy
780,656
+90,515
+13% +$253K 0.01% 729
2024
Q4
$1.12M Buy
690,141
+2,320
+0.3% +$6.92K 0.01% 739
2024
Q3
$2.86M Buy
687,821
+3,627
+0.5% +$19.1K 0.02% 442
2024
Q2
$3.74M Sell
684,194
-214,856
-24% -$1.71M 0.04% 367
2024
Q1
$8.99M Buy
899,050
+214,856
+31% +$1.61M 0.08% 287
2023
Q4
$2.79M Buy
684,194
+330,866
+94% +$1.22M 0.03% 362
2023
Q3
$1.37M Buy
353,328
+3,328
+1% +$17.9K 0.02% 423
2023
Q2
$2.09M Sell
350,000
-350,000
-50% -$2.02M 0.02% 424
2023
Q1
$2.29M Buy
700,000
+76,734
+12% +$307K 0.03% 402
2022
Q4
$2.46M Sell
623,266
-593,650
-49% -$2.9M 0.03% 451
2022
Q3
$7.3M Sell
1,216,916
-106,317
-8% -$767K 0.11% 238
2022
Q2
$8.51M Sell
1,323,233
-228,707
-15% -$1.46M 0.14% 195
2022
Q1
$12.8M Buy
1,551,940
+1,069,234
+222% +$8.64M 0.21% 149
2021
Q4
$7.47M Buy
482,706
+62,839
+15% +$1.21M 0.11% 232
2021
Q3
$9.46M Buy
419,867
+9,019
+2% +$189K 0.16% 171
2021
Q2
$8.08M Buy
410,848
+8,854
+2% +$201K 0.15% 160
2021
Q1
$13.5M Buy
+401,994
New +$13.1M 0.3% 91

Other funds holding SANA